Craft

Allakos

Allakos Summary

Company Summary

Overview
Allakos is a biotechnology company that develops therapeutics targeting allergic, inflammatory, and proliferative diseases. It creates monoclonal antibodies that activate or block inhibitory receptors on immune cells.
Type
Subsidiary
Status
Active
Founded
2012
HQ
San Carlos, CA, US | view all locations
Website
https://www.allakos.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Dan Janney, Chairman

    • Robert Alexander, Chief Executive Officer

      • Robert Andreatta
      • Paul Walker, Director

        LocationsView all

        1 location detected

        • San Carlos, CA HQ

          United States

          825 Industrial Rd #500

        Allakos Financials

        Summary Financials

        Net income (Q1, 2025)
        ($26.2M)
        Cash (Q1, 2025)
        $24.2M
        EBIT (Q1, 2025)
        ($26.7M)

        Footer menu